CHGA and adenocarcinoma: Positive markers for the adenocarcinoma component included CK8/18, CDX2, and C-erB-2, whereas positive markers for the neuroendocrine component included chromogranin A, synaptophysin, CD56, and a high Ki-67 index (~40%).